What is Edgewell Personal Care Company's earnings per share (EPS)?

Edgewell Personal Care Company (EPC) reported diluted earnings per share of $0.53 for fiscal year 2025. This represents a -73.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Edgewell Personal Care Company (EPC) Financials

EPC

Trailing 12 months to June 30, 2026

Revenue $2.2B +11.6% YoY

Net Income -$93.2M -243.8% YoY

EPS (Diluted) -$1.98 -245.6% YoY

Free Cash Flow $52.4M +112.5% YoY

Market Cap $1.3B as of Oct 9, 2026

Price / Sales 0.6x on $2.2B revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 0.9x on $1.5B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EPC SEC filings page.

Edgewell Personal Care Company (EPC) reported $2.2B in revenue over the twelve months to Jun 30, 2026, up 11.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EPC FY2025 2026-10-03

Revenue has stayed nearly flat, but profitability has compressed sharply as operating costs absorb more of each sales dollar.

Revenue was broadly flat from FY2023 through FY2025 while gross margin remained stable; operating margin nevertheless nearly halved, locating the deterioration below gross profit. In FY2025, operating cash flow of $118M exceeded net income of $25M, and free cash flow remained positive after capital spending; earnings converted into cash rather than consuming it.

Selling and administrative expense remained above $400M in FY2025 even as operating income fell to $97M; overhead is consuming a larger share of largely unchanged sales.

The balance sheet showed short-term coverage above 1x with a current ratio of 1.8x, while debt-to-equity was 0.9x. The company repurchased $90M of shares while free cash flow was $41M, so capital returned exceeded internally generated free cash flow that year.

Financial Health Signals

Financial Health Score 37/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Edgewell Personal Care Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Edgewell Personal Care Company has an operating margin of 4.3%, meaning the company retains $4 of operating profit per $100 of revenue. This results in a moderate score of 61/100, indicating healthy but not exceptional operating efficiency. This is down from 8.8% the prior year.

Growth

Edgewell Personal Care Company's revenue declined 1.3% year-over-year, from $2.3B to $2.2B. This contraction results in a growth score of 28/100.

Leverage

Edgewell Personal Care Company has elevated debt relative to equity (D/E of 0.89), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 9/100, reflecting increased financial risk.

Liquidity

Edgewell Personal Care Company's current ratio of 1.76 indicates adequate short-term liquidity, earning a score of 52/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Edgewell Personal Care Company's free cash flow margin of 1.9% results in a low score of 16/100. Capital expenditures of $77.0M absorb a large share of operating cash flow.

Returns

Edgewell Personal Care Company's ROE of 1.6% shows moderate profitability relative to equity, earning a score of 55/100. This is down from 6.2% the prior year.

Altman Z-Score Distress

1.57

Edgewell Personal Care Company scores 1.57, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Edgewell Personal Care Company passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

4.66x

For every $1 of reported earnings, Edgewell Personal Care Company generates $4.66 in operating cash flow ($118.4M OCF vs $25.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

1.32x

Edgewell Personal Care Company earns $1.32 in operating income for every $1 of interest expense ($96.6M vs $73.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$570.1M

YoY+1.7%

QoQ+9.7%

5Y CAGR-0.1%

10Y CAGR-1.2%

Edgewell Personal Care Company generated $570.1M in revenue in Q3 2026. This represents an increase of 1.7% from the same quarter a year earlier. Against the prior quarter it is up 9.7%.

EBITDA

$42.7M

YoY-31.8%

QoQ+16.3%

Edgewell Personal Care Company's EBITDA was $42.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 31.8% from the same quarter a year earlier. Against the prior quarter it is up 16.3%.

Net Income

$13.7M

YoY-52.9%

QoQ+229.2%

5Y CAGR-19.6%

10Y CAGR-9.4%

Edgewell Personal Care Company reported $13.7M in net income in Q3 2026. This represents a decrease of 52.9% from the same quarter a year earlier. Against the prior quarter it is up 229.2%.

EPS (Diluted)

$0.29

YoY-53.2%

QoQ+231.8%

5Y CAGR-17.1%

10Y CAGR-7.2%

Edgewell Personal Care Company earned $0.29 per diluted share (EPS) in Q3 2026. This represents a decrease of 53.2% from the same quarter a year earlier. Against the prior quarter it is up 231.8%.

Cash & Balance Sheet

Free Cash Flow

$103.1M

YoY+3.8%

QoQ+155.8%

5Y CAGR-8.7%

10Y CAGR+5.5%

Edgewell Personal Care Company generated $103.1M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 3.8% from the same quarter a year earlier. Against the prior quarter it is up 155.8%.

Cash & Debt

$397.1M

YoY+98.9%

QoQ+32.5%

5Y CAGR-1.9%

10Y CAGR-5.4%

Edgewell Personal Care Company held $397.1M in cash against $1.2B in long-term debt as of Q3 2026.

Dividends Per Share

$0.15

YoY0.0%

QoQ0.0%

Edgewell Personal Care Company paid $0.15 per share in dividends in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

46M

YoY-0.8%

QoQ0.0%

5Y CAGR-3.2%

10Y CAGR-2.4%

Edgewell Personal Care Company had 46M shares outstanding in Q3 2026. This represents a decrease of 0.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Gross Margin

42.5%

YoY-2.1pp

QoQ+0.8pp

5Y change-4.6pp

10Y change-5.7pp

Edgewell Personal Care Company's gross margin was 42.5% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.8 percentage points.

Operating Margin

4.4%

YoY-3.6pp

QoQ+0.9pp

Edgewell Personal Care Company's operating margin was 4.4% in Q3 2026, reflecting core business profitability. This is down 3.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Net Margin

2.4%

YoY-2.8pp

QoQ+4.4pp

5Y change-4.7pp

10Y change-3.3pp

Edgewell Personal Care Company's net profit margin was 2.4% in Q3 2026, showing the share of revenue converted to profit. This is down 2.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.4 percentage points.

Return on Equity

0.9%

YoY-0.9pp

QoQ+1.7pp

5Y change-1.8pp

10Y change-1.0pp

Edgewell Personal Care Company's ROE was 0.9% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.

Capital Allocation

R&D Spending

$13.3M

YoY-1.5%

QoQ-10.7%

Edgewell Personal Care Company invested $13.3M in research and development in Q3 2026. This represents a decrease of 1.5% from the same quarter a year earlier. Against the prior quarter it is down 10.7%.

Share Buybacks

YoY-100.0%

QoQ-100.0%

Edgewell Personal Care Company repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Capital Expenditures

$15.6M

YoY+0.6%

QoQ+11.4%

5Y CAGR+5.6%

10Y CAGR-0.5%

Edgewell Personal Care Company invested $15.6M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 0.6% from the same quarter a year earlier. Against the prior quarter it is up 11.4%.

EPC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EPC quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$2.2B	$2.2B-1.3%	$2.3B+0.1%	$2.3B+3.7%	$2.2B+4.0%	$2.1B+7.1%	$1.9B-8.9%	$2.1B-4.2%	$2.2B-2.8%	$2.3B-2.7%	$2.4B-2.4%	$2.4B-7.3%	$2.6B+6.7%	$2.4B-46.4%	$4.6B-1.7%	$4.6B
Cost of Revenue	$1.4B	$1.3B0.0%	$1.3B-1.0%	$1.3B+1.5%	$1.3B+13.7%	$1.1B+6.3%	$1.1B-9.0%	$1.2B-2.3%	$1.2B+2.5%	$1.2B-2.5%	$1.2B-2.9%	$1.2B-6.4%	$1.3B+5.8%	$1.2B-48.6%	$2.4B-2.8%	$2.5B
Gross Profit	$885.8M	$924.9M-3.2%	$955.7M+1.6%	$940.8M+6.8%	$880.5M-7.4%	$951.2M+8.0%	$880.9M-8.9%	$966.6M-6.4%	$1.0B-8.3%	$1.1B-2.9%	$1.2B-2.0%	$1.2B-8.2%	$1.3B+7.5%	$1.2B-43.9%	$2.1B-0.4%	$2.1B
R&D Expenses	$59.3M	$57.6M-1.4%	$58.4M-0.2%	$58.5M+5.4%	$55.5M-4.0%	$57.8M+4.5%	$55.3M+3.4%	$53.5M-12.4%	$61.1M-9.6%	$67.6M-6.0%	$71.9M+1.3%	$71.0M+2.2%	$69.5M+0.3%	$69.3M-38.4%	$112.5M+3.9%	$108.3M
SG&A Expenses	$443.6M	$425.0M-1.2%	$430.1M+5.0%	$409.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	$17.8M	$96.6M-51.5%	$199.3M-12.2%	$227.0M+24.5%	$182.3M-24.0%	$239.9M+36.3%	$176.0M-27.8%	$243.8M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA	N/A	$185.4M-35.5%	$287.3M-9.8%	$318.4M+17.0%	$272.2M-16.8%	$327.0M+23.5%	$264.8M-21.6%	$337.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$68.7M	$73.2M-4.3%	$76.5M-2.5%	$78.5M+9.9%	$71.4M+5.2%	$67.9M+10.9%	$61.2M-2.2%	$62.6M-7.9%	$68.0M-1.7%	$69.2M-3.6%	$71.8M-28.1%	$99.8M-16.1%	$119.0M-6.0%	$126.6M-0.5%	$127.3M+4.9%	$121.4M
Income Tax	-$14.9M	-$1.8M-108.1%	$22.3M-32.4%	$33.0M+34.1%	$24.6M-16.0%	$29.3M+48.7%	$19.7M+208.8%	-$18.1M-129.9%	$60.5M+203.2%	-$58.6M-242.2%	$41.2M+125.3%	-$162.6M-678.6%	$28.1M-44.0%	$50.2M-67.9%	$156.5M+8.1%	$144.8M
Net Income	-$93.2M	$25.4M-74.2%	$98.6M-14.0%	$114.7M+15.3%	$99.5M-15.5%	$117.8M+74.3%	$67.6M+118.2%	-$372.2M-460.3%	$103.3M+1712.3%	$5.7M-96.8%	$178.7M+164.9%	-$275.3M-177.3%	$356.1M-12.5%	$407.0M-0.5%	$408.9M+56.5%	$261.2M
EPS (Basic)	N/A	$0.53-73.2%	$1.98-11.6%	$2.24+19.8%	$1.87-13.8%	$2.17+73.6%	$1.25+118.2%	-$6.88-462.1%	$1.90+1800.0%	$0.10-96.7%	$3.02+168.0%	-$4.44-177.4%	$5.74-12.4%	$6.55+4.0%	$6.30+68.0%	$3.75
EPS (Diluted)	-$1.98	$0.53-73.1%	$1.97-10.9%	$2.21+19.5%	$1.85-13.1%	$2.13+71.8%	$1.24+118.0%	-$6.88-462.1%	$1.90+1800.0%	$0.10-96.7%	$2.99+167.3%	-$4.44-178.0%	$5.69-12.1%	$6.47+4.0%	$6.22+67.2%	$3.72
Diluted Shares (Avg)	N/A	48M-5.0%	50M-3.3%	52M-3.4%	54M-2.9%	55M+1.1%	55M+0.9%	54M-0.7%	55M-5.2%	58M-3.7%	60M-3.7%	62M-1.0%	63M-0.5%	63M-4.3%	66M-6.5%	70M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$570.1M+1.7%	$519.5M+0.6%	$422.8M+1.9%	$731.4M+41.3%	$560.4M-13.5%	$516.6M-13.8%	$415.1M-15.1%	$517.6M-3.1%
Cost of Revenue	$327.6M+5.6%	$302.6M+8.2%	$261.8M+7.9%	$466.0M+52.9%	$310.3M-14.0%	$279.7M-18.0%	$242.6M-16.7%	$304.8M
Gross Profit	$242.5M-3.0%	$216.9M-8.4%	$161.0M-6.7%	$265.4M+24.7%	$250.1M-12.9%	$236.9M-8.2%	$172.5M-12.7%	$212.8M-6.9%
R&D Expenses	$13.3M-1.5%	$14.9M+11.2%	$13.8M+3.0%	$17.3M+6.1%	$13.5M-7.5%	$13.4M-5.6%	$13.4M+0.8%	$16.3M
SG&A Expenses	$108.3M+7.5%	$111.0M+8.0%	$102.4M+2.8%	$121.9M+11.6%	$100.7M-8.5%	$102.8M-4.4%	$99.6M-3.6%	$109.2M
Operating Income	$25.0M-44.4%	$18.4M-62.4%	-$18.9M-303.2%	-$6.7M-132.8%	$45.0M-45.6%	$49.0M-30.1%	$9.3M-64.4%	$20.4M
EBITDA	$42.7M-31.8%	$36.7M-44.6%	$2.4M-92.3%	$25.5M-42.0%	$62.6M-39.5%	$66.3M-27.4%	$31.0M-36.2%	$44.0M
Interest Expense	$16.7M-13.9%	$17.9M-11.4%	$19.3M+2.7%	$14.8M-15.4%	$19.4M+3.2%	$20.2M-1.0%	$18.8M-5.1%	$17.5M
Income Tax	$5.7M-18.6%	$3.9M-63.2%	-$7.7M-196.2%	-$16.8M-394.1%	$7.0M-48.1%	$10.6M-3.6%	-$2.6M-316.7%	-$3.4M
Net Income	$13.7M-52.9%	-$10.6M-136.6%	-$65.7M-3028.6%	-$30.6M-447.7%	$29.1M-40.6%	$29.0M-19.4%	-$2.1M-143.8%	$8.8M-70.6%
EPS (Basic)	$0.30-51.6%	-$0.23-138.3%	-$1.41-3425.0%	-$0.64-455.6%	$0.62-37.4%	$0.60-16.7%	-$0.04-140.0%	$0.18-69.5%
EPS (Diluted)	$0.29-53.2%	-$0.22-136.7%	-$1.41-3425.0%	-$0.64-455.6%	$0.62-36.7%	$0.60-16.7%	-$0.04-144.4%	$0.18-69.0%
Diluted Shares (Avg)	47M-0.9%	47M-2.9%	47M-4.3%	N/A	47M-6.2%	48M-4.0%	49M-3.6%	N/A

EPC Balance Sheet

EPC quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$3.8B+0.7%	$3.7B-0.3%	$3.7B+0.7%	$3.7B+1.0%	$3.7B+3.8%	$3.5B+3.5%	$3.4B-13.5%	$4.0B-5.6%	$4.2B-12.2%	$4.8B-4.3%	$5.0B-28.0%	$6.9B+3.1%	$6.7B-0.2%	$6.7B+3.1%	$6.5B
Current Assets	$995.5M+6.4%	$936.0M-2.7%	$962.4M+2.1%	$942.2M-17.0%	$1.1B+15.5%	$983.6M-5.8%	$1.0B+9.8%	$951.2M-19.8%	$1.2B-18.3%	$1.5B-11.3%	$1.6B-40.0%	$2.7B+6.3%	$2.6B+1.8%	$2.5B+11.6%	$2.3B
Cash & Equivalents	$225.7M+7.9%	$209.1M-3.4%	$216.4M+14.7%	$188.7M-60.6%	$479.2M+31.4%	$364.7M+6.8%	$341.6M+28.2%	$266.4M-47.0%	$502.9M-31.9%	$738.9M+3.8%	$712.1M-36.9%	$1.1B+13.1%	$998.3M+38.9%	$718.5M+52.5%	$471.2M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$433.8M-9.1%	$477.3M-3.1%	$492.4M+9.6%	$449.3M+30.0%	$345.7M+10.1%	$314.1M-12.1%	$357.2M+8.4%	$329.5M-1.2%	$333.5M+7.9%	$309.2M-7.1%	$332.8M-46.1%	$616.9M+0.1%	$616.3M-8.3%	$672.4M+2.9%	$653.4M
Accounts Receivable	$137.8M+26.0%	$109.4M+3.0%	$106.2M-22.4%	$136.9M-9.2%	$150.7M-5.1%	$158.8M-22.8%	$205.6M-9.2%	$226.5M+1.1%	$224.1M-14.0%	$260.7M-6.8%	$279.8M-43.5%	$495.0M+3.0%	$480.6M-29.0%	$676.7M-4.7%	$709.8M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.1B-15.1%	$1.3B+0.5%	$1.3B+0.7%	$1.3B+13.7%	$1.2B+0.3%	$1.2B+12.3%	$1.0B-28.8%	$1.5B+0.3%	$1.4B+1.8%	$1.4B-0.1%	$1.4B-4.4%	$1.5B+0.8%	$1.5B+0.4%	$1.5B-0.4%	$1.5B
Total Liabilities	$2.2B+2.6%	$2.1B-2.4%	$2.2B-2.0%	$2.2B+7.4%	$2.1B-0.8%	$2.1B-0.4%	$2.1B-4.1%	$2.2B-9.7%	$2.4B-16.8%	$2.9B-5.8%	$3.1B-29.1%	$4.4B+3.3%	$4.3B-8.5%	$4.7B+5.2%	$4.4B
Current Liabilities	$565.5M+0.3%	$563.6M+7.7%	$523.4M-3.0%	$539.5M+0.5%	$536.8M+5.2%	$510.5M-22.6%	$659.6M-8.0%	$717.0M+36.7%	$524.4M-39.6%	$868.2M+30.2%	$666.8M-57.6%	$1.6B+36.4%	$1.2B-11.8%	$1.3B+27.3%	$1.0B
Non-Current Liabilities	$1.6B+3.4%	$1.6B-5.6%	$1.7B-1.7%	$1.7B+9.8%	$1.6B-2.8%	$1.6B+9.6%	$1.5B-2.3%	$1.5B-22.4%	$1.9B-7.3%	$2.1B-15.5%	$2.5B-13.3%	$2.8B-8.9%	$3.1B-7.3%	$3.4B-1.4%	$3.4B
Long-Term Debt	$1.4B+8.5%	$1.3B-6.3%	$1.4B-2.2%	$1.4B+12.7%	$1.2B-0.3%	$1.2B+12.8%	$1.1B-0.5%	$1.1B-27.6%	$1.5B-1.2%	$1.5B-9.1%	$1.7B-4.0%	$1.8B-11.5%	$2.0B-6.5%	$2.1B-3.1%	$2.2B
Total Equity	$1.6B-2.0%	$1.6B+2.8%	$1.5B+5.0%	$1.5B-7.8%	$1.6B+10.6%	$1.4B+10.4%	$1.3B-25.3%	$1.7B+0.2%	$1.7B-4.8%	$1.8B-1.9%	$1.9B-26.1%	$2.5B+2.8%	$2.5B+18.6%	$2.1B-1.5%	$2.1B
Retained Earnings	$1.1B-0.3%	$1.1B+6.7%	$1.0B+8.8%	$939.1M+8.5%	$865.7M+10.6%	$782.4M+9.5%	$714.8M-34.0%	$1.1B+13.7%	$952.9M+0.7%	$946.0M+22.4%	$772.9M-43.7%	$1.4B+20.0%	$1.1B-61.8%	$3.0B+14.6%	$2.6B

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$3.5B-6.8%	$3.5B-6.4%	$3.8B+1.8%	$3.8B+0.7%	$3.8B+2.3%	$3.8B+0.4%	$3.7B-2.2%	$3.7B-0.3%
Current Assets	$1.1B+10.7%	$1.1B+9.6%	$1.1B+11.8%	$995.5M+6.4%	$1.0B+4.8%	$1.0B+1.8%	$945.2M-6.0%	$936.0M-2.7%
Cash & Equivalents	$397.1M+98.9%	$299.7M+76.2%	$223.3M+27.2%	$225.7M+7.9%	$199.6M+1.8%	$170.1M-13.3%	$175.5M-18.1%	$209.1M-3.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$433.0M-11.3%	$450.1M-12.1%	$461.2M-8.1%	$433.8M-9.1%	$488.4M+7.1%	$512.2M+3.2%	$501.6M-3.9%	$477.3M-3.1%
Accounts Receivable	$119.4M-22.1%	$185.4M+4.0%	$154.0M+27.8%	$137.8M+26.0%	$153.2M-1.2%	$178.2M+36.4%	$120.5M+7.1%	$109.4M+3.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.1B-15.6%	$1.1B-14.9%	$1.1B-14.4%	$1.1B-15.1%	$1.3B+0.7%	$1.3B-0.1%	$1.3B-0.6%	$1.3B+0.5%
Total Liabilities	$2.1B-6.7%	$2.1B-7.7%	$2.3B+3.6%	$2.2B+2.6%	$2.2B+4.4%	$2.3B+2.4%	$2.2B-1.8%	$2.1B-2.4%
Current Liabilities	$603.6M+6.4%	$613.8M+14.5%	$497.5M+8.4%	$565.5M+0.3%	$567.4M+6.0%	$536.3M-1.0%	$459.0M-1.9%	$563.6M+7.7%
Non-Current Liabilities	$1.5B-11.2%	$1.5B-14.6%	$1.8B+2.4%	$1.6B+3.4%	$1.7B+3.8%	$1.7B+3.6%	$1.7B-1.8%	$1.6B-5.6%
Long-Term Debt	$1.2B-9.3%	$1.2B-13.2%	$1.5B+5.6%	$1.4B+8.5%	$1.4B+6.4%	$1.4B+6.1%	$1.4B-0.8%	$1.3B-6.3%
Total Equity	$1.5B-6.9%	$1.4B-4.3%	$1.5B-1.0%	$1.6B-2.0%	$1.6B-0.5%	$1.5B-2.4%	$1.5B-2.9%	$1.6B+2.8%
Retained Earnings	$1.0B-10.9%	$995.8M-9.7%	$1.0B-6.2%	$1.1B-0.3%	$1.1B+3.3%	$1.1B+5.2%	$1.1B+6.0%	$1.1B+6.7%

EPC Cash Flow Statement

EPC quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$121.2M	$118.4M+151.3%	-$231.0M-6.9%	-$216.1M-311.9%	$102.0M-55.5%	$229.0M-1.5%	$232.6M+22.0%	$190.6M-26.5%	$259.4M-17.3%	$313.6M+67.9%	$186.8M+25.5%	$148.8M-74.0%	$572.0M-23.7%	$750.0M+18.7%	$631.6M+53.1%	$412.5M
Depreciation & Amortization	N/A	$88.8M+0.9%	$88.0M-3.7%	$91.4M+1.7%	$89.9M+3.2%	$87.1M-1.9%	$88.8M-5.3%	$93.8M-3.9%	$97.6M+3.4%	$94.4M+1.9%	$92.6M-19.7%	$115.3M-15.3%	$136.2M-5.7%	$144.5M-10.9%	$162.2M-10.5%	$181.3M
Stock-Based Compensation	N/A	$24.5M-7.5%	$26.5M-3.6%	$27.5M+15.5%	$23.8M-12.8%	$27.3M+42.2%	$19.2M+7.9%	$17.8M+4.7%	$17.0M-23.4%	$22.2M-13.3%	$25.6M-22.2%	$32.9M+8.9%	$30.2M-8.5%	$33.0M-26.5%	$44.9M+20.4%	$37.3M
Capital Expenditures	$68.8M	$77.0M+36.3%	$56.5M+14.1%	$49.5M-12.2%	$56.4M-0.7%	$56.8M+19.1%	$47.7M-17.8%	$58.0M-6.5%	$62.0M-10.1%	$69.0M-0.7%	$69.5M-30.1%	$99.4M+16.5%	$85.3M-5.8%	$90.6M-18.4%	$111.0M+13.3%	$98.0M
Free Cash Flow	$52.4M	$41.4M+114.4%	-$287.5M-8.2%	-$265.6M-682.5%	$45.6M-73.5%	$172.2M-6.9%	$184.9M+39.4%	$132.6M-32.8%	$197.4M-19.3%	$244.6M+108.5%	$117.3M+137.4%	$49.4M-89.9%	$486.7M-26.2%	$659.4M+26.7%	$520.6M+65.5%	$314.5M
Investing Cash Flow	$273.4M	-$72.9M-16.8%	-$62.4M-23.6%	-$50.5M+85.8%	-$355.4M-629.8%	-$48.7M+75.2%	-$196.4M-331.6%	-$45.5M+61.7%	-$118.8M-40.4%	-$84.6M-21.7%	-$69.5M+60.2%	-$174.8M+33.6%	-$263.4M-195.6%	-$89.1M+6.1%	-$94.9M+73.9%	-$363.5M
Financing Cash Flow	-$193.8M	-$30.0M+83.3%	-$179.4M-22.5%	-$146.5M-732.4%	-$17.6M+73.1%	-$65.4M-249.7%	-$18.7M+70.7%	-$63.8M+83.2%	-$379.6M+20.6%	-$478.0M-411.8%	-$93.4M+71.5%	-$327.2M-121.5%	-$147.7M+60.9%	-$377.5M-33.3%	-$283.3M-40.2%	-$202.0M
Dividends Paid	$28.4M	$29.3M-4.6%	$30.7M-2.5%	$31.5M-3.4%	$32.6M+27.3%	$25.6M	$0	$0	N/A	$0	$0-100.0%	$93.2M-24.8%	$123.9M+17.3%	$105.6M+324.1%	$24.9M	$0
Share Buybacks	$15.8M	$90.2M+54.2%	$58.5M-22.2%	$75.2M-40.0%	$125.3M+1262.0%	$9.2M	$0	$0-100.0%	$124.4M-24.8%	$165.4M-15.9%	$196.6M+12.2%	$175.2M+85.6%	$94.4M	$0-100.0%	$417.8M+51.4%	$276.0M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$118.7M+3.4%	$54.3M+20.4%	-$125.9M-8.9%	$74.1M+119.1%	$114.8M+13.4%	$45.1M-65.0%	-$115.6M-58.6%	-$388.3M-1.0%
Depreciation & Amortization	$17.7M+0.6%	$18.3M+5.8%	$21.3M-1.8%	$23.2M+8.4%	$17.6M-15.0%	$17.3M-18.4%	$21.7M-3.6%	$21.4M-8.2%
Stock-Based Compensation	N/A	N/A	$3.4M-44.3%	N/A	N/A	N/A	$6.1M-12.9%	N/A
Capital Expenditures	$15.6M+0.6%	$14.0M-18.1%	$11.6M-31.0%	$27.6M+6.6%	$15.5M+23.0%	$17.1M+48.7%	$16.8M+158.5%	$25.9M+40.8%
Free Cash Flow	$103.1M+3.8%	$40.3M+43.9%	-$137.5M-3.9%	$46.5M+111.2%	$99.3M+12.1%	$28.0M-76.2%	-$132.4M-66.8%	-$414.2M-2.8%
Investing Cash Flow	-$14.1M-14.6%	$325.0M+1978.6%	-$9.9M+36.9%	-$27.6M-8.2%	-$12.3M+28.5%	-$17.3M-26.3%	-$15.7M-161.7%	-$25.5M-34.9%
Financing Cash Flow	-$7.3M+91.2%	-$300.8M-704.3%	$133.4M+21.4%	-$19.1M+52.4%	-$83.4M-4.4%	-$37.4M+71.1%	$109.9M+57.4%	-$40.1M-182.4%
Dividends Paid	$7.0M-2.8%	$7.1M-2.7%	$7.4M-6.3%	$6.9M-6.8%	$7.2M-4.0%	$7.3M-11.0%	$7.9M+3.9%	$7.4M-3.9%
Share Buybacks	$0-100.0%	$15.8M-55.4%	$0-100.0%	$0-100.0%	$24.5M+147.5%	$35.4M+131.4%	$30.3M+102.0%	$18.3M-39.0%

EPC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EPC quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	41.6%-0.8pp	42.4%+0.6pp	41.8%+1.2pp	40.5%-5.0pp	45.6%+0.4pp	45.2%0.0pp	45.1%-1.1pp	46.2%-2.8pp	49.0%-0.1pp	49.1%+0.2pp	48.9%-0.5pp	49.4%+0.4pp	49.0%+2.2pp	46.8%+0.6pp	46.2%
Operating Margin	4.3%-4.5pp	8.8%-1.2pp	10.1%+1.7pp	8.4%-3.1pp	11.5%+2.5pp	9.0%-2.4pp	11.4%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	1.1%-3.2pp	4.4%-0.7pp	5.1%+0.5pp	4.6%-1.1pp	5.6%+2.2pp	3.5%+20.9pp	-17.4%-22.0pp	4.6%+4.4pp	0.3%-7.3pp	7.6%+18.9pp	-11.4%-25.0pp	13.6%-3.0pp	16.6%+7.7pp	8.9%+3.3pp	5.6%
Return on Equity	1.6%-4.6pp	6.2%-1.2pp	7.4%+0.7pp	6.8%-0.6pp	7.4%+2.7pp	4.7%+33.2pp	-28.5%-34.5pp	5.9%+5.6pp	0.3%-9.4pp	9.8%+24.5pp	-14.8%-28.9pp	14.1%-2.5pp	16.6%-3.2pp	19.8%+7.3pp	12.4%
Return on Assets	0.7%-2.0pp	2.6%-0.4pp	3.1%+0.4pp	2.7%-0.5pp	3.2%+1.3pp	1.9%+12.8pp	-10.9%-13.5pp	2.6%+2.5pp	0.1%-3.6pp	3.8%+9.3pp	-5.5%-10.7pp	5.1%-0.9pp	6.1%0.0pp	6.1%+2.1pp	4.0%
Current Ratio	1.76+0.1x	1.66-0.2x	1.84+0.1x	1.75-0.4x	2.12+0.2x	1.93+0.3x	1.58+0.3x	1.33-0.9x	2.26+0.6x	1.67-0.8x	2.45+0.7x	1.73-0.5x	2.23+0.3x	1.93-0.3x	2.20
Debt-to-Equity	0.89+0.1x	0.80-0.1x	0.88-0.1x	0.95+0.2x	0.78-0.1x	0.860.0x	0.84+0.2x	0.63-0.2x	0.880.0x	0.84-0.1x	0.91+0.2x	0.70-0.1x	0.81-0.2x	1.030.0x	1.05
Asset Turnover	0.590.0x	0.600.0x	0.600.0x	0.580.0x	0.570.0x	0.55-0.1x	0.63+0.1x	0.570.0x	0.55+0.1x	0.490.0x	0.49+0.1x	0.380.0x	0.36-0.3x	0.680.0x	0.71
FCF Margin	1.9%+14.6pp	-12.8%-1.0pp	-11.8%-13.9pp	2.1%-6.2pp	8.3%-1.2pp	9.5%+3.3pp	6.2%-2.6pp	8.8%-1.8pp	10.6%+5.7pp	5.0%+2.9pp	2.0%-16.6pp	18.6%-8.3pp	26.9%+15.5pp	11.4%+4.6pp	6.8%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	42.5%-2.1pp	41.8%-4.1pp	38.1%-3.5pp	36.3%-4.8pp	44.6%+0.3pp	45.9%+2.8pp	41.6%+1.1pp	41.1%-1.7pp
Operating Margin	4.4%-3.6pp	3.5%-5.9pp	-4.5%-6.7pp	-0.9%-4.9pp	8.0%-4.7pp	9.5%-2.2pp	2.2%-3.1pp	3.9%
Net Margin	2.4%-2.8pp	-2.0%-7.6pp	-15.5%-15.0pp	-4.2%-5.9pp	5.2%-2.4pp	5.6%-0.4pp	-0.5%-1.5pp	1.7%-3.9pp
Return on Equity	0.9%-0.9pp	-0.7%-2.6pp	-4.4%-4.3pp	-2.0%-2.5pp	1.9%-1.3pp	1.9%-0.4pp	-0.1%-0.4pp	0.6%-1.4pp
Return on Assets	0.4%-0.4pp	-0.3%-1.1pp	-1.7%-1.7pp	-0.8%-1.0pp	0.8%-0.5pp	0.8%-0.2pp	-0.1%-0.2pp	0.2%-0.6pp
Current Ratio	1.84+0.1x	1.81-0.1x	2.12+0.1x	1.76+0.1x	1.770.0x	1.89+0.1x	2.06-0.1x	1.66-0.2x
Debt-to-Equity	0.850.0x	0.86-0.1x	1.02+0.1x	0.89+0.1x	0.88+0.1x	0.95+0.1x	0.960.0x	0.80-0.1x
Asset Turnover	0.160.0x	0.150.0x	0.110.0x	0.19+0.1x	0.150.0x	0.140.0x	0.110.0x	0.140.0x
FCF Margin	18.1%+0.4pp	7.8%+2.3pp	-32.5%-0.6pp	6.4%+86.4pp	17.7%+4.0pp	5.4%-14.2pp	-31.9%-15.7pp	-80.0%-4.6pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Edgewell Personal Care Company EPC	FY2025	$2.2B	$25.4M	1.1%	$1.3B	37/100
Yatsen Holding Limited YSG	FY2025	$614.6M	-$11.6M	-1.9%	$235.4M	50/100
Spectrum Brands Holdings, Inc. SPB	FY2025	$2.8B	$99.9M	3.6%	$1.8B	36/100
Helen Of Troy Ltd HELE	FY2026	$1.8B	-$899.0M	-50.3%	$621.0M	32/100
NuSkin Enterprises, Inc. NUS	FY2025	$1.5B	$160.2M	10.8%	$232.2M	40/100
The Honest Company, Inc. HNST	FY2025	$371.3M	-$15.7M	-4.2%	$533.2M	49/100

Where Edgewell Personal Care Company Ranks

Frequently Asked Questions

What is Edgewell Personal Care Company's annual revenue?

Edgewell Personal Care Company (EPC) reported $2.2B in total revenue for fiscal year 2025. This represents a -1.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Edgewell Personal Care Company's revenue growing?

Edgewell Personal Care Company (EPC) revenue declined by 1.3% year-over-year, from $2.3B to $2.2B in fiscal year 2025.

Is Edgewell Personal Care Company profitable?

Yes, Edgewell Personal Care Company (EPC) reported a net income of $25.4M in fiscal year 2025, with a net profit margin of 1.1%.

What is Edgewell Personal Care Company's EBITDA?

Edgewell Personal Care Company (EPC) had EBITDA of $185.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Edgewell Personal Care Company have?

As of fiscal year 2025, Edgewell Personal Care Company (EPC) had $225.7M in cash and equivalents against $1.4B in long-term debt.

What is Edgewell Personal Care Company's gross margin?

Edgewell Personal Care Company (EPC) had a gross margin of 41.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Edgewell Personal Care Company's operating margin?

Edgewell Personal Care Company (EPC) had an operating margin of 4.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Edgewell Personal Care Company's net profit margin?

Edgewell Personal Care Company (EPC) had a net profit margin of 1.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Edgewell Personal Care Company's return on equity (ROE)?

Edgewell Personal Care Company (EPC) has a return on equity of 1.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Edgewell Personal Care Company's free cash flow?

Edgewell Personal Care Company (EPC) generated $41.4M in free cash flow during fiscal year 2025. This represents a 114.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Edgewell Personal Care Company's operating cash flow?

Edgewell Personal Care Company (EPC) generated $118.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Edgewell Personal Care Company's total assets?

Edgewell Personal Care Company (EPC) had $3.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Edgewell Personal Care Company's capital expenditures?

Edgewell Personal Care Company (EPC) invested $77.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Edgewell Personal Care Company spend on research and development?

Edgewell Personal Care Company (EPC) invested $57.6M in research and development during fiscal year 2025.

Does Edgewell Personal Care Company buy back shares?

Yes, Edgewell Personal Care Company (EPC) spent $90.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Edgewell Personal Care Company have outstanding?

Edgewell Personal Care Company (EPC) had 46M shares outstanding as of fiscal year 2025.

What is Edgewell Personal Care Company's current ratio?

Edgewell Personal Care Company (EPC) had a current ratio of 1.76 as of fiscal year 2025, which is generally considered healthy.

What is Edgewell Personal Care Company's debt-to-equity ratio?

Edgewell Personal Care Company (EPC) had a debt-to-equity ratio of 0.89 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Edgewell Personal Care Company's return on assets (ROA)?

Edgewell Personal Care Company (EPC) had a return on assets of 0.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Edgewell Personal Care Company's P/E ratio?

Edgewell Personal Care Company (EPC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.3B as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Edgewell Personal Care Company's price-to-sales ratio?

Edgewell Personal Care Company (EPC) trades at 0.6x sales, its market capitalization divided by revenue of $2.2B revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.3B as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Edgewell Personal Care Company's Altman Z-Score?

Edgewell Personal Care Company (EPC) has an Altman Z-Score of 1.57, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Edgewell Personal Care Company's Piotroski F-Score?

Edgewell Personal Care Company (EPC) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Edgewell Personal Care Company's earnings high quality?

Edgewell Personal Care Company (EPC) has an earnings quality ratio of 4.66x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Edgewell Personal Care Company cover its interest payments?

Edgewell Personal Care Company (EPC) has an interest coverage ratio of 1.32x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Edgewell Personal Care Company?

Edgewell Personal Care Company (EPC) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.